Boston Scientific anticipates Q4 2026 organic revenue down 3% to down 1% and adjusted EPS $0.77-$0.79 amid cyber and EP/WATCHMAN pressure

Stock Market Today: Nasdaq, Small Caps Down After Fed Keeps Rates Steady (Live Coverage)

2026/10/28

3 Dow Jones stocks with questionable fundamentals

2026/10/28

Ticketplus Ltd. GAAP EPS of $0.14 misses by $0.04, revenue of $14.4M beats by $1.51M

2026/10/28

Klabin reports Q3 results

2026/10/28